News by Industry

Cancer

1592 news stories found

img
Press Release November 11, 2026
Creative Biolabs highlights complementary RNA profiling and visualization services to help researchers investigate cell diversity across challenging biological samples.
Read Press Release
img
Press Release October 27, 2026
Tumor organoid and immune cell co-culture services support studies of CAR-T cell interactions with tumor cells in three-dimensional research models.
Read Press Release
img
Press Release October 16, 2026
Recognition marks a new chapter for the oncology-focused biotechnology company as it continues development of its investigational biologic candidate targeting mechanisms associated with cancer recurrence and treatment resistance.
Read Press Release
img
Press Release October 13, 2026
SPRED2 loss drives liver cancer stemness via p53/miR-506-3p/KLF4
Read Press Release
Press Release October 8, 2026
Initiative leverages the MyNavigator™ digital care coordination platform to translate NCCN Guidelines® into actionable home-based education, expand access to integrative oncology services, and empower informal cancer caregivers.
Read Press Release
img
Press Release October 2, 2026
The family-owned pest control and bee removal company is taking its "Mega Bee Goes Pink" campaign into communities across South Florida, with pink uniforms, a month-long brand transformation and 5% of October pest control and bee removal services sup
Read Press Release
img
Press Release October 1, 2026
HCC Lunch & Learn at University of Chicago Medicine will provide patients, caregivers, and at-risk individuals with trusted information about liver health, liver disease, and liver cancer.
Read Press Release
img
Press Release October 1, 2026
Commercial: "The Glue That Should Hold Our Healthcare System Together"
Read Press Release
img
Press Release September 25, 2026
Creative Biolabs today announced the availability of its therapeutic antibody engineering services.
Read Press Release
img
Press Release September 24, 2026
Creative Biolabs has expanded its specialized antibody portfolio targeting structural and envelope proteins from HIV-1, HIV-2, and HTLV-1.
Read Press Release
img
Press Release September 24, 2026
Creative Biolabs officially announced today the expansion of its plant-derived extracellular vesicle development platform to support advancing research in natural nanoscale delivery systems.
Read Press Release
img
Press Release September 17, 2026
"Employers Think Pink" Urges all Companies to Join the Fight Against Breast Cancer by Offering Paid Hours for Mammograms
Read Press Release
img
Press Release September 17, 2026
Creative Biolabs, a global CRO specializing in antibody-drug conjugates (ADCs), is highlighting its integrated bispecific and biparatopic ADC development capabilities.
Read Press Release
img
Press Release September 15, 2026
Two free online workshops presented in Spanish will connect Hispanic and Latino communities with expert guidance on liver health, disease prevention, and liver cancer risk.
Read Press Release
img
Press Release September 10, 2026
Clinical Trial Update on Redsenol-1 Plus for Cancer-Related Fatigue Research
Read Press Release
img
Press Release September 9, 2026
Creative Biolabs has expanded its single-cell analysis capabilities to support increasingly complex biomedical research applications.
Read Press Release
img
Press Release September 9, 2026
Tumor microenvironment drives natural killer cell diversity, reshaping cancer immunotherapy landscape
Read Press Release
Press Release September 1, 2026
UPMC Hillman Cancer Center hematologist, transplant and cell therapy expert recognized among the nation's top 7 percent of physicians
Read Press Release
img
Press Release August 26, 2026
Randomized Controlled Trial Published in the Journal of Human Hypertension Adds to Growing Scientific Interest in Soursop Fruit Juice as a Functional Fruit Beverage
Read Press Release
img
Press Release August 25, 2026
Creative Biolabs will host a live webinar, "Modeling T Cell Dysfunction in Tumor Microenvironments," on September 1, 2026, at 10:00 AM EDT.
Read Press Release